Skip to main content
永顺生物 logo

永顺生物 — Investor Relations & Filings

Ticker · 920729 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 388 across all filing types
Latest filing 2022-11-10 Call Transcript
Country CN China
Listing Beijing Stock Exchange 920729

About 永顺生物

https://www.winsun-gd.com/

Guangdong Winsun Bio-Pharmaceutical Co., Ltd. is a specialized enterprise focused on the research, development, production, and distribution of veterinary biological products. The company primarily develops vaccines for livestock and poultry, with a significant emphasis on swine and avian health. Its product portfolio includes live and inactivated vaccines targeting major diseases such as classical swine fever, porcine reproductive and respiratory syndrome (PRRS), and avian influenza. Winsun Bio-Pharmaceutical leverages advanced biotechnology to provide comprehensive animal disease prevention and control solutions. The company maintains a strong focus on technological innovation and quality management, operating multiple GMP-certified production lines to ensure the efficacy and safety of its biological preparations. Its research initiatives often involve collaborations with academic institutions to advance veterinary medicine and support the animal husbandry sector.

Recent filings

Filing Released Lang Actions
投资者关系活动记录表
Call Transcript Classification · 95% confidence The document is titled as an "投资者关系活动记录表" (Investor Relations Activity Record) and specifically mentions it is a "2022 年第三季度业绩说明会" (2022 Q3 Earnings Explanation Meeting). The content includes detailed Q&A about the company's third quarter performance, market conditions, product strategy, and financial metrics such as gross margin and debt ratio. It is a transcript or summary of an earnings presentation and Q&A session rather than a formal earnings release or quarterly report with financial statements. The document length is 4027 characters, which is relatively short and focused on the earnings call content. This fits the definition of a Call Transcript (CT) rather than an Earnings Release (ER) or Interim Report (IR).
2022-11-10 Chinese
2022 年第三季度业绩说明会预告公告
Call Transcript Classification · 90% confidence The document is a short announcement (885 characters) about a scheduled earnings conference call (业绩说明会) for the third quarter of 2022. It references the previously published 2022 Q3 report but does not contain any financial data or results itself. It provides details on the time, place, and participation method for the earnings call. According to the rules, this is not the earnings release itself but a notice about the earnings call event, which corresponds to a Call Transcript (CT) category when the transcript is provided. However, since this is only a notice of the upcoming earnings call and not the transcript, it is best classified as a Call Transcript (CT) type document because it is an earnings explanation meeting announcement. Confidence is high due to clear keywords like "业绩说明会" (earnings explanation meeting) and the detailed meeting info.
2022-11-03 Chinese
回购进展情况公告
Transaction in Own Shares Classification · 95% confidence The document is a progress announcement regarding the company's share repurchase (buyback) plan. It details the repurchase scheme, including the number of shares repurchased so far, prices, and funds used. It is not a full financial report, earnings release, or management discussion. It is not a regulatory certification or voting result. The document is specifically about the company's own shares repurchase activity, which fits the category of Transaction in Own Shares (POS). The document length is short and focused solely on repurchase progress, confirming it is not a report publication or regulatory filing. Therefore, the correct classification is POS with high confidence.
2022-10-31 Chinese
第四届董事会第十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a meeting resolution announcement from the board of directors of Guangdong Yongshun Biopharmaceutical Co., Ltd. It details the convening and attendance of the 11th meeting of the 4th board, including the approval of the 2022 Q3 report. The document references the actual quarterly report being disclosed elsewhere (on the Beijing Stock Exchange information platform) and does not contain the financial data itself. The document is short (847 characters) and serves as an announcement of the board meeting resolution rather than the report itself. Therefore, it fits best under Board/Management Information (MANG) as it announces board meeting decisions and resolutions.
2022-10-27 Chinese
2022年第三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2022 年第三季度报告" which translates to "2022 Third Quarter Report". It contains detailed financial data including balance sheets, income statements, cash flow statements, and explanations of financial changes for the quarter ending September 30, 2022. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. It explicitly states it is a quarterly report and includes comprehensive financial statements and management discussion. There is no indication that this is an announcement of a report or a certification letter. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q3 2022
2022-10-27 Chinese
第四届监事会第十二次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a meeting resolution announcement from the Supervisory Board of Guangdong Yongshun Biopharmaceutical Co., Ltd. It details the convening and attendance of the 12th meeting of the 4th Supervisory Board, including the approval of the 2022 Q3 report. The document references the actual 2022 Q3 report published elsewhere but does not contain the report itself or substantive financial data. The document is short (800 characters) and serves as an announcement of the meeting resolution and approval of the quarterly report, not the report itself. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and meeting resolution notice.
2022-10-27 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.